Culmination Bio Raises $10M to Bring Longitudinal Health Data to Biopharma
Culmination Bio, a company building the largest disease-agnostic patient data intelligence platform, today announced a $10 million…
Lincoln Nadauld Merck Global Health Innovation Fund Intermountain Health Should Know Culmination Bio Driven Insights Enabled
Source: hitconsultant.net